US VENTURE PARTNERS X LP 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-18 8:04 pm Purchase | 2022-05-10 | 13D | eFFECTOR Therapeutics, Inc. EFTR | US VENTURE PARTNERS X LP | 179,223 10.800% | 179,223 (New Position) | Filing |
| 2022-08-18 7:54 pm Sale | 2022-08-09 | 13D | eFFECTOR Therapeutics, Inc. EFTR | US VENTURE PARTNERS X LP | 0 0.000% | -192,885 (Position Closed) | Filing |
| 2021-09-13 06:23 am Purchase | 2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR | US VENTURE PARTNERS X LP | 192,885 11.900% | 192,885 (New Position) | Filing |